Published in J Affect Disord on January 04, 2012
Preliminary investigation of the influence of dopamine regulating genes on social working memory. Soc Neurosci (2014) 0.78
Cognitive manic symptoms in bipolar disorder associated with polymorphisms in the DAOA and COMT genes. PLoS One (2013) 0.77
The CACNA1C risk allele rs1006737 is associated with age-related prefrontal cortical thinning in bipolar I disorder. Transl Psychiatry (2017) 0.75
Reduced brain activation during inhibitory control in children with COMT Val/Val genotype. Brain Behav (2016) 0.75
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry (2010) 4.85
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry (2010) 2.98
The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry (2010) 1.94
Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology (2010) 1.65
Mental disorders in megacities: findings from the São Paulo megacity mental health survey, Brazil. PLoS One (2012) 1.56
Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry (2010) 1.42
Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci U S A (2009) 1.38
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology (2010) 1.25
Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Int J Neuropsychopharmacol (2006) 1.20
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. J Neurosci (2008) 1.19
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry (2010) 1.12
A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Proc Natl Acad Sci U S A (2010) 1.11
Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10
Does lithium prevent Alzheimer's disease? Drugs Aging (2012) 1.10
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.09
Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology (2008) 1.07
Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep (2011) 1.05
Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. Eur Arch Psychiatry Clin Neurosci (2008) 1.03
Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.03
The detection of depression in medical setting: a study with PRIME-MD. J Affect Disord (2006) 1.00
Clinical predictors of ketamine response in treatment-resistant major depression. J Clin Psychiatry (2014) 1.00
Reduced serum nerve growth factor in patients with late-life depression. Am J Geriatr Psychiatry (2013) 0.98
The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Brief Funct Genomic Proteomic (2007) 0.97
An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. Int J Neuropsychopharmacol (2011) 0.97
Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc (2010) 0.96
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants. Depress Anxiety (2013) 0.95
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis (2010) 0.94
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression. Psychopharmacology (Berl) (2014) 0.93
Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett (2011) 0.93
Recognition of depressive symptoms by physicians. Clinics (Sao Paulo) (2009) 0.93
Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry (2010) 0.91
Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. J Psychiatr Res (2010) 0.91
Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study. Brain Res Bull (2011) 0.89
Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets (2014) 0.89
Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience. Brain Res (2011) 0.88
Use of psychoactive substances and sexual risk behavior in adolescents. Subst Use Misuse (2002) 0.88
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis (2010) 0.88
The immunology of bipolar disorder. Neuroimmunomodulation (2014) 0.87
Burden of maternal bipolar disorder on at-risk offspring: a controlled study on family planning and maternal care. J Affect Disord (2012) 0.87
The more information, the more negative stigma towards schizophrenia: Brazilian general population and psychiatrists compared. Psychiatry Res (2012) 0.86
Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr (2009) 0.85
Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry (2010) 0.85
31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res (2002) 0.84
Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology (2012) 0.84
The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls. J Affect Disord (2012) 0.83
Cognitive dysfunction in depression - pathophysiology and novel targets. CNS Neurol Disord Drug Targets (2014) 0.83
Creativity and executive function across manic, mixed and depressive episodes in bipolar I disorder. J Affect Disord (2011) 0.83
Vocational rehabilitation improves cognition and negative symptoms in schizophrenia. Schizophr Res (2010) 0.83
Association of the COMT Met¹⁵⁸ allele with trait impulsivity in healthy young adults. Mol Med Rep (2013) 0.83
Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int J Neuropsychopharmacol (2013) 0.83
To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2009) 0.83
Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol. CNS Spectr (2009) 0.82
Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment. Eur Arch Psychiatry Clin Neurosci (2014) 0.82
Leukocyte mitochondrial DNA copy number in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.81
Language impairment in euthymic, elderly patients with bipolar disorder but no dementia. Int Psychogeriatr (2008) 0.81
Stigma toward schizophrenia: do all psychiatrists behave the same? Latent profile analysis of a national sample of psychiatrists in Brazil. BMC Psychiatry (2013) 0.81
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: a systematic review and meta-analysis. World J Biol Psychiatry (2014) 0.81
A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania. Hum Psychopharmacol (2005) 0.81
Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl) (2014) 0.81
Novel biomarkers for bipolar disorder. Expert Opin Med Diagn (2012) 0.81
Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? World J Biol Psychiatry (2011) 0.81
SHORT COMMUNICATION: Apolipoprotein E genotype and cognition in bipolar disorder. CNS Neurosci Ther (2010) 0.80
Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial. Psychopharmacology (Berl) (2013) 0.79
Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. Clin Ther (2010) 0.79
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder. Curr Neuropharmacol (2017) 0.78
Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype. Clinics (Sao Paulo) (2013) 0.78
Gender effects of the COMT Val 158 Met genotype on verbal fluency in healthy adults. Mol Med Rep (2013) 0.78
Long-term decrease in immediate early gene expression after electroconvulsive seizures. J Neural Transm (Vienna) (2012) 0.78
COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder. Bipolar Disord (2012) 0.78
Allelic association analysis of phospholipase A2 genes with schizophrenia. Psychiatr Genet (2004) 0.78
Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment. Hum Psychopharmacol (2015) 0.78
[Neuropatological and neurochemical abnormalities in bipolar disorder]. Rev Bras Psiquiatr (2004) 0.77
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. Neuromolecular Med (2015) 0.77
The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole. Trials (2013) 0.77
Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients. Bipolar Disord (2014) 0.77
Cognitive-linguistic deficits in euthymic elderly patients with bipolar disorder. J Affect Disord (2013) 0.77
Facial emotion recognition and its correlation with executive functions in bipolar I patients and healthy controls. J Affect Disord (2013) 0.77
Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders. Curr Opin Psychiatry (2011) 0.76
Does BDNF genotype influence creative output in bipolar I manic patients? J Affect Disord (2012) 0.76
The impact of limbic system morphology on facial emotion recognition in bipolar I disorder and healthy controls. Neuropsychiatr Dis Treat (2013) 0.76
Synaptic plasticity in the pathophysiology and treatment of bipolar disorder. Curr Top Behav Neurosci (2011) 0.76
Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia. Schizophr Res (2013) 0.76
BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis. World J Biol Psychiatry (2014) 0.76
Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania. J Clin Psychopharmacol (2012) 0.76
Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood. J Affect Disord (2012) 0.75
Correction: The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects. PLoS One (2015) 0.75
A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression. J Clin Psychopharmacol (2017) 0.75
Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades. Curr Psychos Ther Rep (2006) 0.75
Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. J Psychiatr Res (2012) 0.75
Formal Thought Disorder and language impairment in schizophrenia. Arq Neuropsiquiatr (2012) 0.75